Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields

PURPOSE: Dexamethasone (Dex) is the most common corticosteroid to treat edema in glioblastoma (GBM) patients. Recent studies identified the addition of Dex to radiation therapy (RT) to be associated with poor survival. Independently, Tumor Treating Fields (TTFields) provides a novel anti-cancer moda...

Descripción completa

Detalles Bibliográficos
Autores principales: Linder, Benedikt, Schiesl, Abigail, Voss, Martin, Rödel, Franz, Hehlgans, Stephanie, Güllülü, Ömer, Seifert, Volker, Kögel, Donat, Senft, Christian, Dubinski, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361446/
https://www.ncbi.nlm.nih.gov/pubmed/34395289
http://dx.doi.org/10.3389/fonc.2021.715031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361446/
https://www.ncbi.nlm.nih.gov/pubmed/34395289
http://dx.doi.org/10.3389/fonc.2021.715031

Ejemplares similares